Consequently, further exploration of the molecular mechanisms underlying TSPYL5’s involvement in BC is warranted, as it may yield critical insights into the development and progression of this disease, potentially paving the way for targeted therapeutic strategies for ER-positive BC patients [41]. Here, TSPYL5 is linked to breast cancer.